AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Telwave M 40mg/50mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Akesiss Pharma Pvt Ltd

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (50mg)

Overview Telwave M 40mg/50mg Tablet ER

Cardiovasc M 40mg/50mg Extended-Release Tablets manage hypertension, reducing the risk of strokes and heart attacks. Prompt use improves heart attack survival rates. Take this medication with food daily at the same time for consistent blood levels, continuing as directed by your physician. Don't discontinue, even feeling well, as hypertension is often asymptomatic; stopping may worsen your condition. Lifestyle changes including regular exercise, weight management, and a healthy diet further aid blood pressure control. Strictly adhere to your doctor's instructions. Potential side effects include headache, weakness, lightheadedness, low blood pressure, elevated potassium, occasional orthostatic hypotension (possibly with fainting), shortness of breath, nausea, vomiting, stomach pain, and tiredness. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolyte levels may be required. Inform your doctor of any liver or kidney issues before starting. Pregnant or breastfeeding individuals should seek medical advice before use. Disclose all other medications, particularly those for hypertension or heart conditions.

Uses of Telwave M 40mg/50mg Tablet ER

Managing Elevated Blood Pressure

Major Benefits of Telwave M 40mg/50mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Telwave M 40mg/50mg Extended-Release Tablet with a meal.

Common Side effects of Telwave M 40mg/50mg Tablet ER:

  • Headache
  • Weakness
  • Dizziness
  • Cold extremities
  • Slow heart rate
  • Increased potassium level in blood
  • Decreased blood pressure
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Breathlessness
  • Vomiting
  • Abdominal pain

How to use Telwave M 40mg/50mg Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Telwave M 40mg/50mg Extended-Release Tablets with a meal.

How Telwave M 40mg/50mg Tablet ER works:

Telmisartan and Metoprolol Succinate, combined in Telwave M 40mg/50mg Extended-Release tablets, effectively reduce blood pressure.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Telwave M 40mg/50mg Extended-Release tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Telwave M 40mg/50mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Telwave M 40mg/50mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Extended-release Telwave M 40mg/50mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Telwave M 40mg/50mg tablets are considered safe for use in individuals with impaired renal function. No alteration to the prescribed dosage of Telwave M 40mg/50mg extended-release tablets is necessary.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Telwave M 40mg/50mg Extended-Release tablets. Dosage modifications for Telwave M 40mg/50mg Extended-Release tablets may be necessary. Physician consultation is advised.

What if you forget to take Telwave M 40mg/50mg Tablet ER :

Should you forget a Telwave M 40mg/50mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Telwave M 40mg/50mg Tablet ER

LabelValue
Addictive None.
Medication Classification Heart-related

FAQs on Telwave M 40mg/50mg Tablet ER

Dizziness is a potential side effect of Telwave M 40mg/50mg Extended-Release Succinate Tablets. This side effect is more likely to occur upon standing after a period of lying down or sitting. To minimize the risk of dizziness or fainting, stand gradually after sitting or lying.
Improving your lifestyle alongside Telwave M 40mg/50mg Tablet ER Succinate use significantly enhances overall well-being. Quitting smoking is crucial, as it elevates the risk of cardiovascular events like heart attack and stroke. Weight management is important; individuals who are overweight or obese should aim for weight loss. A balanced diet rich in fruits and vegetables is recommended. Regular physical activity strengthens the heart and lowers the likelihood of heart attacks.
Continue taking your prescribed Telwave M 40mg/50mg extended-release tablets as directed, even if you're feeling healthy. Abrupt discontinuation of Telwave M 40mg/50mg extended-release tablets can result in severe adverse events, including myocardial infarction and cerebrovascular accident.
Store this medication in its original, tightly sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Telwave M 40mg/50mg Table...
106
MRP 129
17% off